Nektar Therapeutics
NKTR
NKTR
163 hedge funds and large institutions have $1.86B invested in Nektar Therapeutics in 2014 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 49 increasing their positions, 50 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
163
Holders Change
+18
Holders Change %
+12.41%
% of All Funds
4.35%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
40
Increased
49
Reduced
50
Closed
19
Calls
$4.03M
Puts
$2.89M
Net Calls
+$1.14M
Net Calls Change
-$6.97M
Top Buyers
| 1 |
Invesco
Atlanta,
Georgia
|
+$35.6M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$17.2M |
| 3 |
PC
PointState Capital
New York
|
+$15.5M |
| 4 |
DFO
Duquesne Family Office
New York
|
+$10.2M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$7.99M |
Top Sellers
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$22M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
-$17.4M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$15.7M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$13.7M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$5.82M |
